Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.
Patricia J. Sime, Z Xing, Frank L. Graham et al. · Journal of Clinical Investigation · 1997
Transforming growth factor (TGF)-beta1 has been implicated in the pathogenesis of fibrosis based upon its matrix-inducing effects on stromal cells in vitro, and studies demonstrating increased expression of total TGF-beta1 in fibrotic tissues from a variety of organs. The precise role in vivo of this cytokine in both its latent and active forms, however, remains unclear. Using replication-deficient adenovirus vectors to transfer the cDNA of porcine TGF-beta1 to rat lung, we have been able to study the effect of TGF-beta1 protein in the respiratory tract directly. We have demonstrated that transient overexpression of active, but not latent, TGF-beta1 resulted in prolonged and severe interstitial and pleural fibrosis characterized by extensive deposition of the extracellular matrix (ECM) proteins collagen, fibronectin, and elastin, and by emergence of cells with the myofibroblast phenotype. These results illustrate the role of TGF-beta1 and the importance of its activation in the pulmonary fibrotic process, and suggest that targeting active TGF-beta1 and steps involved in TGF-beta1 activation are likely to be valuable antifibrogenic therapeutic strategies. This new and versatile model of pulmonary fibrosis can be used to study such therapies.
Cited by 1,050 works. doi:10.1172/jci119590 Open-access PDF
Authors
References
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
- Determination of hydroxyproline
- Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
- Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
- Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
- Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.
- Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.
- Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.